Literature DB >> 1352424

Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.

L A Trissel1, B B Bready.   

Abstract

The compatibility of taxol in 5% dextrose injection with each of 17 other drugs during simulated Y-site injection was studied through visual and turbidimetric assessment. A 4-mL sample of taxol 1.2 mg/mL in 5% dextrose injection was combined with a 4-mL sample of each of 17 drugs at concentrations that are used clinically. Each combination was prepared in duplicate, with the order of mixing reversed between the two samples. The samples were inspected visually in normal fluorescent light, in high-intensity light, and against light and dark backgrounds with a 3-diopter magnification lens initially and at 30 minutes, one hour, and four hours. A turbidimeter was used to measure the turbidity of each drug combination in triplicate initially and at one and four hours after mixing. None of the drug combinations resulted in visual evidence of precipitation, color change, or gas production, and the turbidity was essentially unchanged over the four-hour observation period. Taxol 1.2 mg/mL in 5% dextrose injection exhibited no visual or turbidimetric evidence of incompatibility when combined with each of 17 other drugs during simulated Y-site injection. However, drug combinations for which no visual or turbidimetric incompatibility is apparent may not be chemically stable; therefore, practitioners should be cautious in applying these findings to the clinical setting.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352424

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  5 in total

1.  Physical Compatibility of Micafungin With Sodium Bicarbonate Hydration Fluids Commonly Used With High-Dose Methotrexate Chemotherapy.

Authors:  Logan C Joiner; Clay Tynes; John Arnold; Rachel R Miller; Greg Gorman
Journal:  Hosp Pharm       Date:  2017-11-01

2.  Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach.

Authors:  Islam M Ghazi; Wasim S El Nekidy; Regan Asay; Paul Fingmori; Anthony Knarr; Mina Awad
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

3.  Sodium Valproate Incompatibility with Parenteral Nutrition Admixtures-A Risk to Patient Safety: An In Vitro Evaluation Study.

Authors:  Ludwika Piwowarczyk; Szymon Tomczak; Patryk Antkowiak; Anna Jelińska; Maciej Stawny
Journal:  Pharmaceutics       Date:  2022-02-07       Impact factor: 6.321

4.  Y-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrations.

Authors:  Kristen R Nichols; Michael W Demarco; Michael D Vertin; Chad A Knoderer
Journal:  Hosp Pharm       Date:  2013-01

5.  Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.

Authors:  Vigdis Staven; Siri Wang; Ingrid Grønlie; Ingunn Tho
Journal:  Nutr J       Date:  2016-03-22       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.